Fundraising FoxVeralox Therapeutics Inc
Frederick, US · Founded 2018 · 1 known investors
Find your way into Veralox Therapeutics Inc
Sign up to see every warm intro you have to Veralox Therapeutics Inc
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Veralox Therapeutics Inc team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Veralox Therapeutics Inc was founded in 2018 by David Maloney, Jeffrey W. Strovel, and Matthew Boxer.
Board
JB
Jonathan BehrBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$39.9M disclosed across 3 rounds · 2019–2023
▶$24MraisedJun 2023 · 14 investors · BiotechnologyRule 506(b)
▶$24MraisedJun 2023 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Megan KrenchDirector
- Alex MartinDirector
- Benjamin ScruggsDirector
- Jamie StiffDirector
- Katie ElliasDirector
- Jonathan MowExecutive Officer, Director
- Offering amount
- $25M
- Amount sold
- $24M
- First sale
- Jun 2023
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$14.4MraisedJul 2021 · 17 investors · BiotechnologyRule 506(b)
▶$14.4MraisedJul 2021 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Benjamin ScruggsDirector
- Jeffrey W. StrovelExecutive Officer, Director
- Jamie StiffDirector
- Katie ElliasDirector
- Christopher GagliardiDirector
- Alex MartinDirector
- Offering amount
- $22.8M
- Amount sold
- $14.4M
- First sale
- Jun 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$1.5MraisedMay 2019 · 6 investors · BiotechnologyRule 506(b)
▶$1.5MraisedMay 2019 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- David MaloneyExecutive Officer, Director
- Jonathan BehrDirector
- Jeffrey W. StrovelExecutive Officer, Director
- Matthew BoxerExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $1.5M
- Minimum investment
- $25K
- First sale
- May 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Veralox Therapeutics Inc?
- Veralox Therapeutics Inc was founded by David Maloney, Jeffrey W. Strovel, Matthew Boxer in 2018.
- Who are Veralox Therapeutics Inc's investors?
- Veralox Therapeutics Inc's investors include Genesys Capital.
- How much funding has Veralox Therapeutics Inc raised?
- Veralox Therapeutics Inc has disclosed $39.9M raised across 3 rounds.
- Where is Veralox Therapeutics Inc headquartered?
- Veralox Therapeutics Inc is headquartered in Frederick, US.